Treatment beliefs, health behaviors and their association with treatment outcome in type 2 diabetes

par von Arx, Lill-Brith Wium, Gydesen, Helge, Skovlund, Søren
Publié dans BMJ Open Diabetes Res Care (2016)

Performance of claims-based algorithms for identifying incident thyroid cancer in commercial health plan enrollees receiving antidiabetic drug therapies

par Funch, Donnie, Ross, Douglas, Gardstein, Betsey M., Norman, Heather S., Sanders, Lauren A., Major-Pedersen, Atheline, Gydesen, Helge, Dore, David D.
Publié dans BMC Health Serv Res (2017)

Clinical Effectiveness of Liraglutide vs Sitagliptin on Glycemic Control and Body Weight in Patients with Type 2 Diabetes: A Retrospective Assessment in Sweden

par Lind, Marcus, Matsson, Per-Olov, Linder, Ragnar, Svenningsson, Irene, Jørgensen, Leif, Ploug, Uffe J., Gydesen, Helge, Dorkhan, Mozhgan, Larsen, Sara, Johansson, Gunnar
Publié dans Diabetes Ther (2016)

Comparison of the HAT study, the largest global hypoglycaemia study to date, with similar large real‐world studies

par Pedersen‐Bjergaard, Ulrik, Alsifri, Saud, Aronson, Ronnie, Berković, Maja Cigrovski, Galstyan, Gagik, Gydesen, Helge, Lekdorf, Jesper Barner, Ludvik, Bernhard, Moberg, Erik, Ramachandran, Ambady, Khunti, Kamlesh
Publié dans Diabetes Obes Metab (2018)

Liraglutide use and evaluation of pancreatic outcomes in a US commercially insured population

par Funch, Donnie, Mortimer, Kathleen, Ziyadeh, Najat J., Seeger, John D., Li, Ling, Norman, Heather, Major‐Pedersen, Atheline, Bosch‐Traberg, Heidrun, Gydesen, Helge, Dore, David D.
Publié dans Diabetes Obes Metab (2019)

Risk of Thyroid Cancer Associated with Use of Liraglutide and Other Antidiabetic Drugs in a US Commercially Insured Population

par Funch, Donnie, Mortimer, Kathleen, Ziyadeh, Najat J, D Seeger, John, Zhou, Li, Ng, Eva, Ross, Douglas, Major-Pedersen, Atheline, Bosch-Traberg, Heidrun, Gydesen, Helge, Dore, David D
Publié dans Diabetes Metab Syndr Obes (2021)